- Management of primary and secondary tumours of the central nervous system, eyes and pediatric malignancies
- Methods of optimizing radiation treatment for malignancies of the brain by conformal radiation therapy and/or sensitizing agents
- Determining the value of stereotactically directed radiation therapy for primary tumours of the eye
- Investigating predictive values of MRI spectroscopy/PET changes relative to recurrence patterns of malignant glioma in brain
Normand J Laperriere
Clinical outcomes of hypofractionated radiation therapy for choroidal metastases: Symptom palliation, tumor control, and survival.
Pract Radiat Oncol. 2017 Jun 29;:
Chin Clin Oncol. 2017 Aug;6(4):39
Monte Carlo-driven predictions of neurocognitive and hearing impairments following proton and photon radiotherapy for pediatric brain-tumor patients.
J Neurooncol. 2017 Aug 19;:
J Clin Oncol. 2015 Oct 10;33(29_suppl):194
Nat Commun. 2017 Aug 04;8(1):186
N Engl J Med. 2017 06 01;376(22):2197
Can J Neurol Sci. 2017 May;44(3):288-294
Radiosurgery for brainstem metastases with and without whole brain radiotherapy: clinical series and literature review.
J Radiat Oncol. 2017;6(1):21-30
Neutrophil-lymphocyte ratio dynamics during concurrent chemo-radiotherapy for glioblastoma is an independent predictor for overall survival.
J Neurooncol. 2017 Mar 22;:
N Engl J Med. 2017 03 16;376(11):1027-1037
Cancer Clinical Research Unit (CCRU), Princess Margaret Cancer Centre
Professor, Department of Radiation Oncology, University of Toronto
Staff Radiation Oncologist, Princess Margaret Cancer Centre
Associate Director, Gerry and Nancy Pencer Brain Tumour Centre, Princess Margaret Cancer Centre